array(3) { ["company_details"]=> array(13) { ["name"]=> string(26) "Bio-RAD Laboratories, Inc." ["slug"]=> string(33) "001cd-us-bio-rad-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920" ["description"]=> string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together. #Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics" ["address_street"]=> string(20) "1000 Alfred Nobel Dr" ["address_place"]=> string(8) "Hercules" ["address_region"]=> string(10) "California" ["founding_date"]=> string(10) "1952-02-08" ["website_domain"]=> string(11) "bio-rad.com" ["website_url"]=> string(23) "https://www.bio-rad.com" ["industry_codes"]=> array(3) { [0]=> string(42) "In Vitro and In Vivo Diagnostic Substances" [1]=> string(33) "Laboratory Analytical Instruments" [2]=> string(47) "Electromedical and Electrotherapeutic Apparatus" } ["employee_count"]=> int(7900) ["article_count"]=> int(659) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(92) "Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Crosses Above 50-Day Moving Average of $324.95" ["snippet_en"]=> string(222) "Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report)’s share price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $324.95 and traded as high as $334.10." ["url"]=> string(133) "https://www.defenseworld.net/2024/03/05/bio-rad-laboratories-nysebio-b-stock-price-crosses-above-50-day-moving-average-of-324-95.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2f4ef90c-1d67-4755-a782-9192e45a5ff3" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2024-03-05" ["categories"]=> array(1) { [0]=> string(12) "Stock Market" } } [1]=> array(7) { ["title_en"]=> string(73) "Scope Fluidics (WSE:SCP) - Stock Price, News & Analysis - Simply Wall St" ["snippet_en"]=> string(155) "Research Scope Fluidics' (WSE:SCP) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more." ["url"]=> string(72) "https://simplywall.st/stocks/pl/healthcare/wse-scp/scope-fluidics-shares" ["image_url"]=> string(78) "https://images.businessradar.com/articles/6d70ed64-378e-46e9-bb90-37dead2c5896" ["source"]=> string(13) "simplywall.st" ["publication_date"]=> string(10) "2024-02-26" ["categories"]=> array(5) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(15) "Market Movement" [2]=> string(9) "Valuation" [3]=> string(18) "General Investment" [4]=> string(12) "Stock Market" } } [2]=> array(7) { ["title_en"]=> string(80) "Bio-Rad Laboratories (NYSE:BIO) - Stock Price, News & Analysis - Simply Wall St" ["snippet_en"]=> string(162) "Research Bio-Rad Laboratories' (NYSE:BIO) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more." ["url"]=> string(85) "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bio/bio-rad-laboratories" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8141cc14-f185-4b4b-8269-b0c9b83caef8" ["source"]=> string(13) "simplywall.st" ["publication_date"]=> string(10) "2024-01-24" ["categories"]=> array(5) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(15) "Market Movement" [2]=> string(10) "Executives" [3]=> string(12) "Stock Market" [4]=> string(12) "Board Change" } } [3]=> array(7) { ["title_en"]=> string(84) "Zacks Research Weighs in on Bio-Rad Laboratories, Inc.'s Q1 2025 Earnings (NYSE:BIO)" ["snippet_en"]=> string(300) "Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Stock analysts at Zacks Research cut their Q1 2025 EPS estimates for Bio-Rad Laboratories in a research note issued to investors on Tuesday, January 16th. Zacks Research analyst R. Anand now forecasts that the medical research company will pos" ["url"]=> string(89) "https://www.marketbeat.com/instant-alerts/nyse-bio-analyst-earnings-estimates-2024-01-19/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4c2cc902-3ad5-47d1-82b6-b5f42dbe6540" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-19" ["categories"]=> array(7) { [0]=> string(13) "Credit Rating" [1]=> string(24) "Stock Research & Ratings" [2]=> string(24) "Quarterly/Annual Figures" [3]=> string(5) "R & D" [4]=> string(12) "Stock Market" [5]=> string(9) "Investors" [6]=> string(17) "Academic Research" } } [4]=> array(7) { ["title_en"]=> string(74) "Implied Volatility Surging for On Bio-Rad Laboratories (BIO) Stock Options" ["snippet_en"]=> string(230) "Investors in Bio-Rad Laboratories, Inc. BIO need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 15, 2023 $240.00 Call had some of the highest implied volatility of all equi" ["url"]=> string(104) "https://www.nasdaq.com/articles/implied-volatility-surging-for-on-bio-rad-laboratories-bio-stock-options" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-11-20" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(9) "Investors" [2]=> string(15) "Market Movement" } } [5]=> array(7) { ["title_en"]=> string(67) "Not Big Tech – 3 S&P 500 Stocks With the Highest Upside Potential" ["snippet_en"]=> string(152) "The S&P 500 (SPX) just had its best week of 2023, as it gained about 5.9%. Still, there are a few S&P 500 stocks (not the same old big tech stocks) that" ["url"]=> string(94) "https://news-24.fr/pas-big-tech-3-actions-du-sp-500-avec-le-potentiel-de-hausse-le-plus-eleve/" ["image_url"]=> NULL ["source"]=> string(10) "news-24.fr" ["publication_date"]=> string(10) "2023-11-04" ["categories"]=> array(1) { [0]=> string(12) "Stock Market" } } [6]=> array(7) { ["title_en"]=> string(66) "Bio-Rad Laboratories (BIO) Q3 Earnings and Revenues Miss Estimates" ["snippet_en"]=> string(188) "Bio-Rad (BIO) delivered earnings and revenue surprises of -18.82% and 8.47%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?" ["url"]=> string(73) "https://finance.yahoo.com/news/bio-rad-laboratories-bio-q3-214015742.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/54218d72-8d2f-496a-b2cb-e093122752ad" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-10-26" ["categories"]=> array(3) { [0]=> string(24) "Quarterly/Annual Figures" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(12) "Stock Market" } } [7]=> array(7) { ["title_en"]=> string(52) "Bio-Rad Shares Drop After Company Reports 3Q Results" ["snippet_en"]=> string(160) "By Stephen Nakrosis Shares of Bio-Rad Laboratories were trading lower in the after-hours market following the release of third-quarter financial results that..." ["url"]=> string(95) "https://www.marketwatch.com/story/bio-rad-shares-drop-after-company-reports-3q-results-0d9c70ab" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3bebe02f-4333-46c5-bde4-e8e5d9bb24c2" ["source"]=> string(15) "marketwatch.com" ["publication_date"]=> string(10) "2023-10-26" ["categories"]=> array(7) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Stock Research & Ratings" [2]=> string(15) "Market Movement" [3]=> string(14) "Issuing Shares" [4]=> string(12) "Stock Market" [5]=> string(21) "Financial Performance" [6]=> string(24) "Quarterly/Annual Figures" } } [8]=> array(7) { ["title_en"]=> string(62) "Investors are worried about growing volatility | Investing.com" ["snippet_en"]=> string(143) "Alexey Kalachev: market overview, including XAU/USD, S&P 500, Dow Jones Industrial Average, Nikkei 225. Latest market analysis on Investing.com" ["url"]=> string(51) "https://ru.investing.com/analysis/article-200308103" ["image_url"]=> NULL ["source"]=> string(13) "investing.com" ["publication_date"]=> string(10) "2023-10-18" ["categories"]=> array(12) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Stock Research & Ratings" [2]=> string(15) "Market Movement" [3]=> string(14) "Issuing Shares" [4]=> string(5) "Debts" [5]=> string(19) "Investment Requests" [6]=> string(18) "General Investment" [7]=> string(12) "Stock Market" [8]=> string(16) "Share Repurchase" [9]=> string(24) "Quarterly/Annual Figures" [10]=> string(25) "Business Model Resilience" [11]=> string(11) "Acquisition" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(66) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(51) } [2]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(31) } [3]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(28) } [4]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(26) } [5]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(23) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(20) } [8]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(19) } [9]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(19) } [11]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(18) } [12]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(14) } [13]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(14) } [14]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(13) } [15]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(13) } [16]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(9) } [17]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(9) } [18]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(9) } [19]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [20]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(8) } [21]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(7) } [24]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(7) } [25]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(15) "Business Ethics" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(5) } } } 001cd-us-bio-rad-laboratories-inc